XII
Detailed Valuation Scenarios
================================================================================
VALUATION SCENARIOS - DISCOUNTED CASH FLOW (DCF) ANALYSIS
================================================================================
📊 LLM-DETERMINED DCF PARAMETERS FOR UNH
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
UNH is a managed care giant facing significant near-term headwinds (Change Healthcare breach aftermath, rising medical loss ratios, DOJ investigation) that have compressed 2024-2025 earnings and FCF well below mid-cycle levels. I normalize base FCF to $17.5B reflecting partial OCF recovery from the current trough, as the roic.ai FCF/share series ($22-28 range in 2022-2023) confirms current figures are anomalously depressed. WACC reflects moderate leverage ($30B net debt) and elevated regulatory/operational uncertainty.
Scenario Parameters (LLM-selected based on fundamental analysis):
🔻 Bear: 4.0% growth, 10.5% WACC, 2.0% terminal
→ Regulatory headwinds intensify with Medicare Advantage rate cuts, DOJ action constrains vertical integration, medical loss ratios remain structurally elevated, and Optum growth decelerates amid increased antitrust scrutiny.
⚖️ Base: 7.0% growth, 9.5% WACC, 2.5% terminal
→ UNH gradually recovers margins as Change Healthcare disruption fades, Optum drives mid-to-high single-digit organic growth, and underlying healthcare spending tailwinds (~5-6% market growth) support 7-9% revenue growth with modest operating leverage.
🔺 Bull: 10.0% growth, 9.0% WACC, 2.5% terminal
→ Full margin recovery plus Optum Health and Optum Insight accelerate through AI-driven care delivery efficiencies, regulatory concerns prove manageable, and UNH extends its dominant position in the $4.5T US healthcare ecosystem with share buybacks further boosting per-share FCF growth.
Base FCF: Current 2025 FCF of $11B is severely depressed by Change Healthcare costs, elevated medical costs, and DOJ disruption. Historical roic.ai FCF/share averaged $22-28 in 2022-2023 (~$20-25B total). Normalizing to $17.5B reflects partial recovery acknowledging that some margin pressure (higher MLR, regulatory scrutiny) may persist structurally. Reported FCF for UNH is also distorted by insurance portfolio investment activity.
Stock: UNH
Current Price: $275.59
Shares Outstanding: 0.91B (905,838,620 shares)
Base Year FCF (FY 2025): $17.5B (from financial statements)
--------------------------------------------------------------------------------
BEAR CASE (Probability: 25%)
Conservative: Below-trend growth, elevated risk premium, modest recession impact
📊 CASH FLOW NOTE: LLM analysis: Current 2025 FCF of $11B is severely depressed by Change Healthcare costs, elevated medical costs, and DOJ disruption. Historical roic.ai FCF/share averaged $22-28 in 2022-2023 (~$20-25B total). Normalizing to $17.5B reflects partial recovery acknowledging that some margin pressure (higher MLR, regulatory scrutiny) may persist structurally. Reported FCF for UNH is also distorted by insurance portfolio investment activity.
ASSUMPTIONS:
• FCF Growth Rate (Years 1-10): 4.0%
• Discount Rate (WACC): 10.5%
• Terminal Growth Rate: 2.0%
10-YEAR FCF PROJECTION:
Year FCF ($M) PV Factor PV of FCF ($M)
------------------------------------------------------------
1 $18,200,000,000 0.9050 $16,470,588,235
2 $18,928,000,000 0.8190 $15,501,730,104
3 $19,685,120,000 0.7412 $14,589,863,627
4 $20,472,524,800 0.6707 $13,731,636,355
5 $21,291,425,792 0.6070 $12,923,893,040
6 $22,143,082,824 0.5493 $12,163,664,038
7 $23,028,806,137 0.4971 $11,448,154,388
8 $23,949,958,382 0.4499 $10,774,733,542
9 $24,907,956,717 0.4071 $10,140,925,687
10 $25,904,274,986 0.3684 $9,544,400,646
------------------------------------------------------------
Total PV of 10-Year FCF: $127,289,589,662
TERMINAL VALUE:
• Year 11 FCF: $26,422,360,486
• Terminal Value: $310,851,299,833
• PV of Terminal Value: $114,532,807,754
VALUATION SUMMARY:
• Enterprise Value: $241.8B
• Less: Total Debt: $78.4B
• Plus: Cash & Equivalents: $48.2B
• Equity Value: $211.6B
• Shares Outstanding: 0.91B
• Intrinsic Value per Share: $233.60
• Current Price: $275.59
• Upside/Downside: -15.2%
• Margin of Safety: -18.0%
--------------------------------------------------------------------------------
BASE CASE (Probability: 50%)
Balanced: Sustainable growth trajectory, market-appropriate discount rate, realistic perpetuity assumptions
📊 CASH FLOW NOTE: LLM analysis: Current 2025 FCF of $11B is severely depressed by Change Healthcare costs, elevated medical costs, and DOJ disruption. Historical roic.ai FCF/share averaged $22-28 in 2022-2023 (~$20-25B total). Normalizing to $17.5B reflects partial recovery acknowledging that some margin pressure (higher MLR, regulatory scrutiny) may persist structurally. Reported FCF for UNH is also distorted by insurance portfolio investment activity.
ASSUMPTIONS:
• FCF Growth Rate (Years 1-10): 7.0%
• Discount Rate (WACC): 9.5%
• Terminal Growth Rate: 2.5%
10-YEAR FCF PROJECTION:
Year FCF ($M) PV Factor PV of FCF ($M)
------------------------------------------------------------
1 $18,725,000,000 0.9132 $17,100,456,621
2 $20,035,750,000 0.8340 $16,710,035,237
3 $21,438,252,500 0.7617 $16,328,527,583
4 $22,938,930,175 0.6956 $15,955,730,150
5 $24,544,655,287 0.6352 $15,591,444,073
6 $26,262,781,157 0.5801 $15,235,475,030
7 $28,101,175,838 0.5298 $14,887,633,135
8 $30,068,258,147 0.4838 $14,547,732,835
9 $32,173,036,217 0.4418 $14,215,592,816
10 $34,425,148,753 0.4035 $13,891,035,902
------------------------------------------------------------
Total PV of 10-Year FCF: $154,463,663,383
TERMINAL VALUE:
• Year 11 FCF: $35,285,777,471
• Terminal Value: $504,082,535,305
• PV of Terminal Value: $203,404,454,283
VALUATION SUMMARY:
• Enterprise Value: $357.9B
• Less: Total Debt: $78.4B
• Plus: Cash & Equivalents: $48.2B
• Equity Value: $327.6B
• Shares Outstanding: 0.91B
• Intrinsic Value per Share: $361.71
• Current Price: $275.59
• Upside/Downside: +31.2%
• Margin of Safety: 23.8%
--------------------------------------------------------------------------------
BULL CASE (Probability: 25%)
Optimistic: Strong execution, market share gains, operating leverage, sustained competitive advantages
📊 CASH FLOW NOTE: LLM analysis: Current 2025 FCF of $11B is severely depressed by Change Healthcare costs, elevated medical costs, and DOJ disruption. Historical roic.ai FCF/share averaged $22-28 in 2022-2023 (~$20-25B total). Normalizing to $17.5B reflects partial recovery acknowledging that some margin pressure (higher MLR, regulatory scrutiny) may persist structurally. Reported FCF for UNH is also distorted by insurance portfolio investment activity.
ASSUMPTIONS:
• FCF Growth Rate (Years 1-10): 10.0%
• Discount Rate (WACC): 9.0%
• Terminal Growth Rate: 2.5%
10-YEAR FCF PROJECTION:
Year FCF ($M) PV Factor PV of FCF ($M)
------------------------------------------------------------
1 $19,250,000,000 0.9174 $17,660,550,459
2 $21,175,000,000 0.8417 $17,822,573,857
3 $23,292,500,000 0.7722 $17,986,083,709
4 $25,621,750,000 0.7084 $18,151,093,652
5 $28,183,925,000 0.6499 $18,317,617,447
6 $31,002,317,500 0.5963 $18,485,668,983
7 $34,102,549,250 0.5470 $18,655,262,276
8 $37,512,804,175 0.5019 $18,826,411,471
9 $41,264,084,593 0.4604 $18,999,130,843
10 $45,390,493,052 0.4224 $19,173,434,795
------------------------------------------------------------
Total PV of 10-Year FCF: $184,077,827,492
TERMINAL VALUE:
• Year 11 FCF: $46,525,255,378
• Terminal Value: $715,773,159,662
• PV of Terminal Value: $302,350,317,927
VALUATION SUMMARY:
• Enterprise Value: $486.4B
• Less: Total Debt: $78.4B
• Plus: Cash & Equivalents: $48.2B
• Equity Value: $456.2B
• Shares Outstanding: 0.91B
• Intrinsic Value per Share: $503.63
• Current Price: $275.59
• Upside/Downside: +82.7%
• Margin of Safety: 45.3%
--------------------------------------------------------------------------------
================================================================================
SENSITIVITY ANALYSIS - Intrinsic Value per Share
================================================================================
How intrinsic value changes with different growth and discount rates:
Growth → 3% 5% 8% 10% 12% 15%
WACC ↓ ------------------------------------------------------------------
8% $ 341 $ 404↑ $ 520↑ $ 613↑ $ 722↑ $ 919↑
9% $ 283 $ 334 $ 428↑ $ 504↑ $ 591↑ $ 750↑
10% $ 240↓ $ 283 $ 361↑ $ 424↑ $ 496↑ $ 627↑
11% $ 208↓ $ 244↓ $ 310 $ 363↑ $ 424↑ $ 534↑
12% $ 182↓ $ 214↓ $ 271 $ 316 $ 368↑ $ 462↑
Current Price: $275.59
Base FCF: $17.5B
Terminal Growth: 2.5% (constant)
Legend: ↑ = 30%+ upside | ↓ = 10%+ downside
================================================================================
================================================================================
REVERSE DCF — WHAT IS THE MARKET PRICING IN?
================================================================================
Using IDENTICAL assumptions as Base Case DCF:
• WACC (Discount Rate): 9.5%
• Terminal Growth Rate: 2.5%
• Base FCF: $17.5B
• Current Price: $275.59
→ Market-Implied FCF Growth Rate: 3.7%
→ Base Case uses: 7.0% growth → $361.71/share
📊 Market is pricing in LOWER growth (3.7%) than our Base Case (7.0%)
→ Potential upside if company achieves base case growth
================================================================================
================================================================================
PROBABILITY-WEIGHTED VALUATION
================================================================================
Bear Case (233.60) × 25% = $58.40
Base Case (361.71) × 50% = $180.85
Bull Case (503.63) × 25% = $125.91
========================================
Weighted Average Intrinsic Value: $365.16
Current Price: $275.59
Upside/Downside: +32.5%
Margin of Safety: 24.5%
================================================================================